• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and China Animal Blood Plasma and Derivatives Market Insights, Forecast to 2026

report cover
  • 4 September 2020
  • Pharmaceuticals
  • 130 Pages
  • Report Code: 24LS-21570
  • Formate :   
Download FREE Report Sample Download PDF File

Animal Blood Plasma Derivatives -MARKET ADVISORY SERVICES

Animal Blood Plasma and Derivatives market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Animal Blood Plasma and Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Animal Blood Plasma and Derivatives market is segmented into
By Derivatives Type
By Animal Type

Segment by Application, the Animal Blood Plasma and Derivatives market is segmented into
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others

Regional and Country-level Analysis
The Animal Blood Plasma and Derivatives market is analysed and market size information is provided by regions (countries).
The key regions covered in the Animal Blood Plasma and Derivatives market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Animal Blood Plasma and Derivatives Market Share Analysis
Animal Blood Plasma and Derivatives market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Animal Blood Plasma and Derivatives business, the date to enter into the Animal Blood Plasma and Derivatives market, Animal Blood Plasma and Derivatives product introduction, recent developments, etc.
The major vendors covered:
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.
1 Study Coverage
1.1 Animal Blood Plasma and Derivatives Product Introduction
1.2 Market Segments
1.3 Key Animal Blood Plasma and Derivatives Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Application
1.5.2 Food & Beverages
1.5.3 Pharmaceuticals
1.5.4 Cosmetics
1.5.5 Feed
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Animal Blood Plasma and Derivatives Market Size, Estimates and Forecasts
2.1.1 Global Animal Blood Plasma and Derivatives Revenue 2015-2026
2.1.2 Global Animal Blood Plasma and Derivatives Sales 2015-2026
2.2 Global Animal Blood Plasma and Derivatives, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Animal Blood Plasma and Derivatives Historical Market Size by Region (2015-2020)
2.3.1 Global Animal Blood Plasma and Derivatives Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Animal Blood Plasma and Derivatives Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Animal Blood Plasma and Derivatives Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Region (2021-2026)
2.4.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Region (2021-2026)

3 Global Animal Blood Plasma and Derivatives Competitor Landscape by Players
3.1 Global Top Animal Blood Plasma and Derivatives Sales by Manufacturers
3.1.1 Global Animal Blood Plasma and Derivatives Sales by Manufacturers (2015-2020)
3.1.2 Global Animal Blood Plasma and Derivatives Sales Market Share by Manufacturers (2015-2020)
3.2 Global Animal Blood Plasma and Derivatives Manufacturers by Revenue
3.2.1 Global Animal Blood Plasma and Derivatives Revenue by Manufacturers (2015-2020)
3.2.2 Global Animal Blood Plasma and Derivatives Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Animal Blood Plasma and Derivatives Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Animal Blood Plasma and Derivatives Revenue in 2019
3.2.5 Global Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Animal Blood Plasma and Derivatives Price by Manufacturers
3.4 Global Animal Blood Plasma and Derivatives Manufacturing Base Distribution, Product Types
3.4.1 Animal Blood Plasma and Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Animal Blood Plasma and Derivatives Product Type
3.4.3 Date of International Manufacturers Enter into Animal Blood Plasma and Derivatives Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Animal Blood Plasma and Derivatives Market Size by Type (2015-2020)
4.1.1 Global Animal Blood Plasma and Derivatives Sales by Type (2015-2020)
4.1.2 Global Animal Blood Plasma and Derivatives Revenue by Type (2015-2020)
4.1.3 Animal Blood Plasma and Derivatives Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Animal Blood Plasma and Derivatives Market Size Forecast by Type (2021-2026)
4.2.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Type (2021-2026)
4.2.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Type (2021-2026)
4.2.3 Animal Blood Plasma and Derivatives Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Animal Blood Plasma and Derivatives Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Animal Blood Plasma and Derivatives Market Size by Application (2015-2020)
5.1.1 Global Animal Blood Plasma and Derivatives Sales by Application (2015-2020)
5.1.2 Global Animal Blood Plasma and Derivatives Revenue by Application (2015-2020)
5.1.3 Animal Blood Plasma and Derivatives Price by Application (2015-2020)
5.2 Animal Blood Plasma and Derivatives Market Size Forecast by Application (2021-2026)
5.2.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Application (2021-2026)
5.2.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Application (2021-2026)
5.2.3 Global Animal Blood Plasma and Derivatives Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
6.1 China Animal Blood Plasma and Derivatives Market Size YoY Growth 2015-2026
6.1.1 China Animal Blood Plasma and Derivatives Sales YoY Growth 2015-2026
6.1.2 China Animal Blood Plasma and Derivatives Revenue YoY Growth 2015-2026
6.1.3 China Animal Blood Plasma and Derivatives Market Share in Global Market 2015-2026
6.2 China Animal Blood Plasma and Derivatives Market Size by Players (International and Local Players)
6.2.1 China Top Animal Blood Plasma and Derivatives Players by Sales (2015-2020)
6.2.2 China Top Animal Blood Plasma and Derivatives Players by Revenue (2015-2020)
6.3 China Animal Blood Plasma and Derivatives Historic Market Review by Type (2015-2020)
6.3.1 China Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
6.3.2 China Animal Blood Plasma and Derivatives Revenue Market Share by Type (2015-2020)
6.3.3 China Animal Blood Plasma and Derivatives Price by Type (2015-2020)
6.4 China Animal Blood Plasma and Derivatives Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Animal Blood Plasma and Derivatives Sales Forecast by Type (2021-2026)
6.4.2 China Animal Blood Plasma and Derivatives Revenue Forecast by Type (2021-2026)
6.4.3 China Animal Blood Plasma and Derivatives Price Forecast by Type (2021-2026)
6.5 China Animal Blood Plasma and Derivatives Historic Market Review by Application (2015-2020)
6.5.1 China Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
6.5.2 China Animal Blood Plasma and Derivatives Revenue Market Share by Application (2015-2020)
6.5.3 China Animal Blood Plasma and Derivatives Price by Application (2015-2020)
6.6 China Animal Blood Plasma and Derivatives Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Animal Blood Plasma and Derivatives Sales Forecast by Application (2021-2026)
6.6.2 China Animal Blood Plasma and Derivatives Revenue Forecast by Application (2021-2026)
6.6.3 China Animal Blood Plasma and Derivatives Price Forecast by Application (2021-2026)

7 North America
7.1 North America Animal Blood Plasma and Derivatives Market Size YoY Growth 2015-2026
7.2 North America Animal Blood Plasma and Derivatives Market Facts & Figures by Country
7.2.1 North America Animal Blood Plasma and Derivatives Sales by Country (2015-2020)
7.2.2 North America Animal Blood Plasma and Derivatives Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Animal Blood Plasma and Derivatives Market Size YoY Growth 2015-2026
8.2 Europe Animal Blood Plasma and Derivatives Market Facts & Figures by Country
8.2.1 Europe Animal Blood Plasma and Derivatives Sales by Country
8.2.2 Europe Animal Blood Plasma and Derivatives Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Animal Blood Plasma and Derivatives Market Size YoY Growth 2015-2026
9.2 Asia Pacific Animal Blood Plasma and Derivatives Market Facts & Figures by Country
9.2.1 Asia Pacific Animal Blood Plasma and Derivatives Sales by Region (2015-2020)
9.2.2 Asia Pacific Animal Blood Plasma and Derivatives Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Animal Blood Plasma and Derivatives Market Size YoY Growth 2015-2026
10.2 Latin America Animal Blood Plasma and Derivatives Market Facts & Figures by Country
10.2.1 Latin America Animal Blood Plasma and Derivatives Sales by Country
10.2.2 Latin America Animal Blood Plasma and Derivatives Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Animal Blood Plasma and Derivatives Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Animal Blood Plasma and Derivatives Market Facts & Figures by Country
11.2.1 Middle East and Africa Animal Blood Plasma and Derivatives Sales by Country
11.2.2 Middle East and Africa Animal Blood Plasma and Derivatives Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Proliant Inc.
12.1.1 Proliant Inc. Corporation Information
12.1.2 Proliant Inc. Description and Business Overview
12.1.3 Proliant Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Products Offered
12.1.5 Proliant Inc. Recent Development
12.2 Thermo Fisher Scientific, Inc.
12.2.1 Thermo Fisher Scientific, Inc. Corporation Information
12.2.2 Thermo Fisher Scientific, Inc. Description and Business Overview
12.2.3 Thermo Fisher Scientific, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Products Offered
12.2.5 Thermo Fisher Scientific, Inc. Recent Development
12.3 Merck KGaA
12.3.1 Merck KGaA Corporation Information
12.3.2 Merck KGaA Description and Business Overview
12.3.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck KGaA Animal Blood Plasma and Derivatives Products Offered
12.3.5 Merck KGaA Recent Development
12.4 Kraeber & Co GmbH
12.4.1 Kraeber & Co GmbH Corporation Information
12.4.2 Kraeber & Co GmbH Description and Business Overview
12.4.3 Kraeber & Co GmbH Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Products Offered
12.4.5 Kraeber & Co GmbH Recent Development
12.5 LAMPIRE Biological Laboratories, Inc.
12.5.1 LAMPIRE Biological Laboratories, Inc. Corporation Information
12.5.2 LAMPIRE Biological Laboratories, Inc. Description and Business Overview
12.5.3 LAMPIRE Biological Laboratories, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Products Offered
12.5.5 LAMPIRE Biological Laboratories, Inc. Recent Development
12.6 Lake Immunogenics, Inc.
12.6.1 Lake Immunogenics, Inc. Corporation Information
12.6.2 Lake Immunogenics, Inc. Description and Business Overview
12.6.3 Lake Immunogenics, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Products Offered
12.6.5 Lake Immunogenics, Inc. Recent Development
12.7 Rocky Mountain Biologicals Inc.
12.7.1 Rocky Mountain Biologicals Inc. Corporation Information
12.7.2 Rocky Mountain Biologicals Inc. Description and Business Overview
12.7.3 Rocky Mountain Biologicals Inc. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Products Offered
12.7.5 Rocky Mountain Biologicals Inc. Recent Development
12.8 ANZCO Foods Ltd.
12.8.1 ANZCO Foods Ltd. Corporation Information
12.8.2 ANZCO Foods Ltd. Description and Business Overview
12.8.3 ANZCO Foods Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Products Offered
12.8.5 ANZCO Foods Ltd. Recent Development
12.9 Auckland BioSciences Ltd.
12.9.1 Auckland BioSciences Ltd. Corporation Information
12.9.2 Auckland BioSciences Ltd. Description and Business Overview
12.9.3 Auckland BioSciences Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Products Offered
12.9.5 Auckland BioSciences Ltd. Recent Development
12.10 Bovogen Biologicals Pty Ltd.
12.10.1 Bovogen Biologicals Pty Ltd. Corporation Information
12.10.2 Bovogen Biologicals Pty Ltd. Description and Business Overview
12.10.3 Bovogen Biologicals Pty Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Products Offered
12.10.5 Bovogen Biologicals Pty Ltd. Recent Development
12.11 Proliant Inc.
12.11.1 Proliant Inc. Corporation Information
12.11.2 Proliant Inc. Description and Business Overview
12.11.3 Proliant Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Proliant Inc. Animal Blood Plasma and Derivatives Products Offered
12.11.5 Proliant Inc. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Animal Blood Plasma and Derivatives Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Animal Blood Plasma and Derivatives Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Animal Blood Plasma and Derivatives Market Segments

Table 2. Ranking of Global Top Animal Blood Plasma and Derivatives Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type 2020-2026 (K L) & (US$ Million)

Table 4. Major Manufacturers of Type I

Table 5. Major Manufacturers of Type II

Table 6. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Application 2020-2026 (K L)

Table 7. Global Animal Blood Plasma and Derivatives Market Size by Region (K L) & (US$ Million): 2020 VS 2026

Table 8. Global Animal Blood Plasma and Derivatives Sales by Regions 2015-2020 (K L)

Table 9. Global Animal Blood Plasma and Derivatives Sales Market Share by Regions (2015-2020)

Table 10. Global Animal Blood Plasma and Derivatives Revenue by Regions 2015-2020 (US$ Million)

Table 11. Global Animal Blood Plasma and Derivatives Sales Forecast by Region (2021-2026) (K L)

Table 12. Global Animal Blood Plasma and Derivatives Sales by Manufacturers (2015-2020) (K L)

Table 13. Global Animal Blood Plasma and Derivatives Sales Share by Manufacturers (2015-2020)

Table 14. Global Animal Blood Plasma and Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 15. Global Animal Blood Plasma and Derivatives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Blood Plasma and Derivatives as of 2019)

Table 16. Animal Blood Plasma and Derivatives Revenue by Manufacturers (2015-2020) (US$ Million)

Table 17. Animal Blood Plasma and Derivatives Revenue Share by Manufacturers (2015-2020)

Table 18. Key Manufacturers Animal Blood Plasma and Derivatives Price (2015-2020) (USD/L)

Table 19. Animal Blood Plasma and Derivatives Manufacturers Manufacturing Base Distribution and Headquarters

Table 20. Manufacturers Animal Blood Plasma and Derivatives Product Type

Table 21. Date of International Manufacturers Enter into Animal Blood Plasma and Derivatives Market

Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 23. Global Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)

Table 24. Global Animal Blood Plasma and Derivatives Sales Share by Type (2015-2020)

Table 25. Global Animal Blood Plasma and Derivatives Revenue by Type (2015-2020) (US$ Million)

Table 26. Global Animal Blood Plasma and Derivatives Revenue Share by Type (2015-2020)

Table 27. Animal Blood Plasma and Derivatives Average Selling Price (ASP) by Type 2015-2020 (USD/L)

Table 28. Global Animal Blood Plasma and Derivatives Sales Share by Type (2021-2026)

Table 29. Global Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)

Table 30. Global Animal Blood Plasma and Derivatives Sales Share by Application (2015-2020)

Table 31. Global Animal Blood Plasma and Derivatives Sales Share by Application (2021-2026)

Table 32. Global Animal Blood Plasma and Derivatives Sales Market Share Forecast by Application (2021-2026)

Table 33. Global Animal Blood Plasma and Derivatives Revenue by Application (2015-2020) (US$ Million)

Table 34. Global Animal Blood Plasma and Derivatives Revenue Market Share Forecast by Application (2021-2026)

Table 35. China Animal Blood Plasma and Derivatives Sales (K L) of Key Companies (2015-2020)

Table 36. China Animal Blood Plasma and Derivatives Sales Share by Company (2015-2020)

Table 37. China Animal Blood Plasma and Derivatives Revenue (US$ Million) by Company (2015-2020)

Table 38. China Animal Blood Plasma and Derivatives Sales (K L) by Type (2015-2020)

Table 39. China Animal Blood Plasma and Derivatives Sales Share by Type (2015-2020)

Table 40. China Animal Blood Plasma and Derivatives Revenue (US$ Million) Market Share by Type (2015-2020)

Table 41. China Animal Blood Plasma and Derivatives Price (K L) by Type (2015-2020)

Table 42. China Animal Blood Plasma and Derivatives Sales (K L) by Type (2021-2026)

Table 43. China Animal Blood Plasma and Derivatives Sales Share by Type (2021-2026)

Table 44. China Animal Blood Plasma and Derivatives Revenue (US$ Million) Market Share by Type (2021-2026)

Table 45. China Animal Blood Plasma and Derivatives Revenue Share by Type (2021-2026)

Table 46. China Animal Blood Plasma and Derivatives Price (K L) by Type (2021-2026)

Table 47. China Animal Blood Plasma and Derivatives Sales (K L) by Application (2015-2020)

Table 48. China Animal Blood Plasma and Derivatives Sales Share by Application (2015-2020)

Table 49. China Animal Blood Plasma and Derivatives Revenue (US$ Million) Market Share by Application (2015-2020)

Table 50. China Animal Blood Plasma and Derivatives Sales (K L) by Application (2021-2026)

Table 51. China Animal Blood Plasma and Derivatives Sales Share by Application (2021-2026)

Table 52. China Animal Blood Plasma and Derivatives Revenue (US$ Million) Market Share by Application (2021-2026)

Table 53. China Animal Blood Plasma and Derivatives Revenue Share by Application (2021-2026)

Table 54. North America Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)

Table 55. North America Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)

Table 56. North America Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)

Table 57. North America Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)

Table 58. Europe Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)

Table 59. Europe Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)

Table 60. Europe Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)

Table 61. Europe Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)

Table 62. Asia Pacific Animal Blood Plasma and Derivatives Sales by Region (2015-2020) (K L)

Table 63. Asia Pacific Animal Blood Plasma and Derivatives Sales Market Share by Region (2015-2020)

Table 64. Asia Pacific Animal Blood Plasma and Derivatives Revenue by Region (2015-2020) (US$ Million)

Table 65. Asia Pacific Animal Blood Plasma and Derivatives Revenue Market Share by Region (2015-2020)

Table 66. Latin America Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)

Table 67. Latin America Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)

Table 68. Latin Americaa Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)

Table 69. Latin America Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)

Table 70. Middle East and Africa Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)

Table 71. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)

Table 72. Middle East and Africa Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)

Table 73. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)

Table 74. Proliant Inc. Corporation Information

Table 75. Proliant Inc. Description and Business Overview

Table 76. Proliant Inc. Animal Blood Plasma and Derivatives Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)

Table 77. Proliant Inc. Animal Blood Plasma and Derivatives Product

Table 78. Proliant Inc. Recent Development

Table 79. Thermo Fisher Scientific, Inc. Corporation Information

Table 80. Thermo Fisher Scientific, Inc. Description and Business Overview

Table 81. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)

Table 82. Thermo Fisher Scientific, Inc. Product

Table 83. Thermo Fisher Scientific, Inc. Recent Development

Table 84. Merck KGaA Corporation Information

Table 85. Merck KGaA Description and Business Overview

Table 86. Merck KGaA Animal Blood Plasma and Derivatives Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)

Table 87. Merck KGaA Product

Table 88. Merck KGaA Recent Development

Table 89. Kraeber & Co GmbH Corporation Information

Table 90. Kraeber & Co GmbH Description and Business Overview

Table 91. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)

Table 92. Kraeber & Co GmbH Product

Table 93. Kraeber & Co GmbH Recent Development

Table 94. LAMPIRE Biological Laboratories, Inc. Corporation Information

Table 95. LAMPIRE Biological Laboratories, Inc. Description and Business Overview

Table 96. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)

Table 97. LAMPIRE Biological Laboratories, Inc. Product

Table 98. LAMPIRE Biological Laboratories, Inc. Recent Development

Table 99. Lake Immunogenics, Inc. Corporation Information

Table 100. Lake Immunogenics, Inc. Description and Business Overview

Table 101. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)

Table 102. Lake Immunogenics, Inc. Product

Table 103. Lake Immunogenics, Inc. Recent Development

Table 104. Rocky Mountain Biologicals Inc. Corporation Information

Table 105. Rocky Mountain Biologicals Inc. Description and Business Overview

Table 106. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)

Table 107. Rocky Mountain Biologicals Inc. Product

Table 108. Rocky Mountain Biologicals Inc. Recent Development

Table 109. ANZCO Foods Ltd. Corporation Information

Table 110. ANZCO Foods Ltd. Description and Business Overview

Table 111. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)

Table 112. ANZCO Foods Ltd. Product

Table 113. ANZCO Foods Ltd. Recent Development

Table 114. Auckland BioSciences Ltd. Corporation Information

Table 115. Auckland BioSciences Ltd. Description and Business Overview

Table 116. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)

Table 117. Auckland BioSciences Ltd. Product

Table 118. Auckland BioSciences Ltd. Recent Development

Table 119. Bovogen Biologicals Pty Ltd. Corporation Information

Table 120. Bovogen Biologicals Pty Ltd. Description and Business Overview

Table 121. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)

Table 122. Bovogen Biologicals Pty Ltd. Product

Table 123. Bovogen Biologicals Pty Ltd. Recent Development

Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 125. Key Challenges

Table 126. Market Risks

Table 127. Main Points Interviewed from Key Animal Blood Plasma and Derivatives Players

Table 128. Animal Blood Plasma and Derivatives Customers List

Table 129. Animal Blood Plasma and Derivatives Distributors List

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Animal Blood Plasma and Derivatives Product Picture

Figure 2. Global Animal Blood Plasma and Derivatives Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Animal Blood Plasma and Derivatives Sales Market Share by Application in 2020 & 2026

Figure 6. Food & Beverages

Figure 7. Pharmaceuticals

Figure 8. Cosmetics

Figure 9. Feed

Figure 10. Others

Figure 11. Animal Blood Plasma and Derivatives Report Years Considered

Figure 12. Global Animal Blood Plasma and Derivatives Market Size 2015-2026 (US$ Million)

Figure 13. Global Animal Blood Plasma and Derivatives Sales 2015-2026 (K L)

Figure 14. Global Animal Blood Plasma and Derivatives Market Size Market Share by Region: 2020 Versus 2026

Figure 15. Global Animal Blood Plasma and Derivatives Sales Market Share by Region (2015-2020)

Figure 16. Global Animal Blood Plasma and Derivatives Sales Market Share by Region in 2019

Figure 17. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region (2015-2020)

Figure 18. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region in 2019

Figure 19. Global Animal Blood Plasma and Derivatives Sales Share by Manufacturer in 2019

Figure 20. The Top 10 and 5 Players Market Share by Animal Blood Plasma and Derivatives Revenue in 2019

Figure 21. Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 22. Global Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)

Figure 23. Global Animal Blood Plasma and Derivatives Sales Market Share by Type in 2019

Figure 24. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2015-2020)

Figure 25. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type in 2019

Figure 26. Global Animal Blood Plasma and Derivatives Market Share by Price Range (2015-2020)

Figure 27. Global Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)

Figure 28. Global Animal Blood Plasma and Derivatives Sales Market Share by Application in 2019

Figure 29. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2015-2020)

Figure 30. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application in 2019

Figure 31. China Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2026 (K L)

Figure 32. China Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2026 (US$ Million)

Figure 33. China Animal Blood Plasma and Derivatives Market Share in Global Market 2015-2026

Figure 34. China 5 and 10 Largest Animal Blood Plasma and Derivatives Players Market Share by Revenue in Animal Blood Plasma and Derivatives in 2019

Figure 35. China Animal Blood Plasma and Derivatives Revenue Share by Type (2015-2020)

Figure 36. China Animal Blood Plasma and Derivatives Revenue Growth Rate by Type in 2015 & 2019

Figure 37. China Animal Blood Plasma and Derivatives Revenue Share by Application (2015-2020)

Figure 38. China Animal Blood Plasma and Derivatives Revenue Growth Rate by Application in 2015 & 2019

Figure 39. North America Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)

Figure 40. North America Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)

Figure 41. North America Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019

Figure 42. North America Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019

Figure 43. U.S. Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 44. U.S. Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 45. Canada Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 46. Canada Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 47. Europe Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)

Figure 48. Europe Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)

Figure 49. Europe Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019

Figure 50. Europe Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019

Figure 51. Germany Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 52. Germany Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. France Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 54. France Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. U.K. Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 56. U.K. Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Italy Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 58. Italy Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Russia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 60. Russia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 61. Asia Pacific Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)

Figure 62. Asia Pacific Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)

Figure 63. Asia Pacific Animal Blood Plasma and Derivatives Sales Market Share by Region in 2019

Figure 64. Asia Pacific Animal Blood Plasma and Derivatives Revenue Market Share by Region in 2019

Figure 65. China Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 66. China Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. Japan Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 68. Japan Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. South Korea Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 70. South Korea Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. India Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 72. India Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Australia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 74. Australia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Taiwan Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 76. Taiwan Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Indonesia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 78. Indonesia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Thailand Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 80. Thailand Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Malaysia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 82. Malaysia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Philippines Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 84. Philippines Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Vietnam Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 86. Vietnam Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 87. Latin America Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)

Figure 88. Latin America Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)

Figure 89. Latin America Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019

Figure 90. Latin America Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019

Figure 91. Mexico Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 92. Mexico Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 93. Brazil Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 94. Brazil Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Argentina Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 96. Argentina Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 97. Middle East and Africa Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)

Figure 98. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)

Figure 99. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019

Figure 100. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019

Figure 101. Turkey Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 102. Turkey Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 103. Saudi Arabia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 104. Saudi Arabia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. U.A.E Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)

Figure 106. U.A.E Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)

Figure 107. Porter's Five Forces Analysis

Figure 108. Animal Blood Plasma and Derivatives Value Chain

Figure 109. Channels of Distribution

Figure 110. Distributors Profiles

Figure 111. Bottom-up and Top-down Approaches for This Report

Figure 112. Data Triangulation

Figure 113. Key Executives Interviewed

Proliant Inc.

Thermo Fisher Scientific, Inc.

Merck KGaA

Kraeber & Co GmbH

LAMPIRE Biological Laboratories, Inc.

Lake Immunogenics, Inc.

Rocky Mountain Biologicals Inc.

ANZCO Foods Ltd.

Auckland BioSciences Ltd.

Bovogen Biologicals Pty Ltd.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3237

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase